SGEN Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $0.00 = $0
SGEN Prices
View the SGEN historical prices.
52WL $197.99
The 52 Week Low is $197.99 set on Tue, Jun 6, 2023.
52WH $314.83
The 52 Week High is $314.83 set on Mon, Mar 4, 2024. The current price, $0.00, is 0% below the 52 Week High.
ATH $0.00
The All-Time High is $0.00 set on Wed, Dec 31, 1969.
52 Week Range
SGEN Dividends
SGEN has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
SGEN Profile
Seagen Inc. (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers. Seagen's therapies are based on antibody-drug conjugate technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, Adcetris, has received approval for six indications to treat Hodgkin lymphoma and T-cell lymphoma. Other approved products include Padcev for bladder cancer, Tukysa for breast cancer, and Tivdak for cervical cancer. The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to several leading biotechnology and pharmaceutical companies.
